Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-936-98.
Published December 17, 2025 · Recall initiated: October 24, 2025
Summary
FDA records drug Class II recall D-0217-2026, published December 17, 2025 and initiated October 24, 2025. Recalling firm: Cipla USA, Inc.; Status: Ongoing; Reported quantity: 1180 boxes; Lot: lot# NB240315, exp 12/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed stability specifications: Out of specification for hardness test
What to do
Voluntary: Firm initiated
Get an email if LANTHANUM CARBONATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LANTHANUM CARBONATE
- Manufacturer
- Cipla USA, Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0369097935894
- Lot
- lot# NB240315, exp 12/31/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by:December 17, 2025
- FDAVarenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJDecember 17, 2025
- FDAGanirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, RxDecember 17, 2025
- FDACT 5300; Software Version Number: 4.5, 5.0, 5.1;December 10, 2025
- FDAMAMMOMAT Fusion;December 10, 2025
- FDAMAMMOMAT Inspiration;December 10, 2025
Questions about this recall
Was Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-936-98. recalled?
Yes. FDA published recall D-0217-2026 on December 17, 2025. Reported hazard: Failed stability specifications: Out of specification for hardness test
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LANTHANUM CARBONATE. UPC: 0369097935894.